These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 35378080)

  • 1. Modeling insights into SARS-CoV-2 respiratory tract infections prior to immune protection.
    Chen A; Wessler T; Daftari K; Hinton K; Boucher RC; Pickles R; Freeman R; Lai SK; Forest MG
    Biophys J; 2022 May; 121(9):1619-1631. PubMed ID: 35378080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneity in transmissibility and shedding SARS-CoV-2 via droplets and aerosols.
    Chen PZ; Bobrovitz N; Premji Z; Koopmans M; Fisman DN; Gu FX
    Elife; 2021 Apr; 10():. PubMed ID: 33861198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A hybrid discrete-continuum model of immune responses to SARS-CoV-2 infection in the lung alveolar region, with a focus on interferon induced innate response.
    Aristotelous AC; Chen A; Forest MG
    J Theor Biol; 2022 Dec; 555():111293. PubMed ID: 36208668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling identifies variability in SARS-CoV-2 uptake and eclipse phase by infected cells as principal drivers of extreme variability in nasal viral load in the 48 h post infection.
    Pearson J; Wessler T; Chen A; Boucher RC; Freeman R; Lai SK; Pickles R; Forest MG
    J Theor Biol; 2023 May; 565():111470. PubMed ID: 36965846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deposition distribution of the new coronavirus (SARS-CoV-2) in the human airways upon exposure to cough-generated droplets and aerosol particles.
    Madas BG; Füri P; Farkas Á; Nagy A; Czitrovszky A; Balásházy I; Schay GG; Horváth A
    Sci Rep; 2020 Dec; 10(1):22430. PubMed ID: 33384436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Viral Load of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Respiratory Aerosols Emitted by Patients With Coronavirus Disease 2019 (COVID-19) While Breathing, Talking, and Singing.
    Coleman KK; Tay DJW; Tan KS; Ong SWX; Than TS; Koh MH; Chin YQ; Nasir H; Mak TM; Chu JJH; Milton DK; Chow VTK; Tambyah PA; Chen M; Tham KW
    Clin Infect Dis; 2022 May; 74(10):1722-1728. PubMed ID: 34358292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody protection from SARS-CoV-2 respiratory tract exposure and infection.
    Chen A; Wessler T; Gregory Forest M
    J Theor Biol; 2023 Jan; 557():111334. PubMed ID: 36306828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucosal Gene Expression in Response to SARS-CoV-2 Is Associated with Viral Load.
    Rajagopala SV; Strickland BA; Pakala SB; Kimura KS; Shilts MH; Rosas-Salazar C; Brown HM; Freeman MH; Wessinger BC; Gupta V; Phillips E; Mallal SA; Turner JH; Das SR
    J Virol; 2023 Feb; 97(2):e0147822. PubMed ID: 36656015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenesis and transmission of SARS-CoV-2 in golden hamsters.
    Sia SF; Yan LM; Chin AWH; Fung K; Choy KT; Wong AYL; Kaewpreedee P; Perera RAPM; Poon LLM; Nicholls JM; Peiris M; Yen HL
    Nature; 2020 Jul; 583(7818):834-838. PubMed ID: 32408338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].
    ; ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2024 Feb; 47(2):101-119. PubMed ID: 38309959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative Microbial Risk Assessment for Airborne Transmission of SARS-CoV-2 via Breathing, Speaking, Singing, Coughing, and Sneezing.
    Schijven J; Vermeulen LC; Swart A; Meijer A; Duizer E; de Roda Husman AM
    Environ Health Perspect; 2021 Apr; 129(4):47002. PubMed ID: 33793301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Universal screening for SARS-CoV-2 infection: a rapid review.
    Viswanathan M; Kahwati L; Jahn B; Giger K; Dobrescu AI; Hill C; Klerings I; Meixner J; Persad E; Teufer B; Gartlehner G
    Cochrane Database Syst Rev; 2020 Sep; 9(9):CD013718. PubMed ID: 33502003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human Nasal Epithelial Cells Sustain Persistent SARS-CoV-2 Infection
    Gamage AM; Tan KS; Chan WOY; Lew ZZR; Liu J; Tan CW; Rajagopalan D; Lin QXX; Tan LM; Venkatesh PN; Ong YK; Thong M; Lin RTP; Prabhakar S; Wang Y; Wang LF
    mBio; 2022 Feb; 13(1):e0343621. PubMed ID: 35038898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computational Modeling Insights into Extreme Heterogeneity in COVID-19 Nasal Swab Data.
    Zhang L; Cao H; Medlin K; Pearson J; Aristotelous AC; Chen A; Wessler T; Forest MG
    Viruses; 2023 Dec; 16(1):. PubMed ID: 38257769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of Airborne Influenza A and SARS-CoV-2 Virus Shedding following Ocular Inoculation of Ferrets.
    Belser JA; Sun X; Kieran TJ; Brock N; Pulit-Penaloza JA; Pappas C; Basu Thakur P; Jones J; Wentworth DE; Zhou B; Tumpey TM; Maines TR
    J Virol; 2022 Dec; 96(24):e0140322. PubMed ID: 36448801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of primary COVID-19 pneumonia: plausible airborne transmission of SARS-CoV-2.
    Dumont-Leblond N; Duchaine C; Veillette M; Pen V; Bergevin M
    Eur J Med Res; 2022 Apr; 27(1):50. PubMed ID: 35379338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transmission and Protection against Reinfection in the Ferret Model with the SARS-CoV-2 USA-WA1/2020 Reference Isolate.
    Patel DR; Field CJ; Septer KM; Sim DG; Jones MJ; Heinly TA; Vanderford TH; McGraw EA; Sutton TC
    J Virol; 2021 Jun; 95(13):e0223220. PubMed ID: 33827954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Respiratory epithelial cell responses to SARS-CoV-2 in COVID-19.
    Bridges JP; Vladar EK; Huang H; Mason RJ
    Thorax; 2022 Feb; 77(2):203-209. PubMed ID: 34404754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SPIKE-1: A Randomised Phase II/III trial in a community setting, assessing use of camostat in reducing the clinical progression of COVID-19 by blocking SARS-CoV-2 Spike protein-initiated membrane fusion.
    Halford S; Wan S; Dragoni I; Silvester J; Nazarov B; Anthony D; Anthony S; Ladds E; Norrie J; Dhaliwal K;
    Trials; 2021 Aug; 22(1):550. PubMed ID: 34412682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.